ArticleiScience2022
Biparatopic nanobodies targeting the receptor binding domain efficiently neutralize SARS-CoV-2.
Phillip Pymm et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ArticleiScience2022
Phillip Pymm et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.